Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive genetic testing experience for myocilin primary open-angle glaucoma using the Australian and New Zealand Registry of Advanced Glaucoma.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Jul 2014

Souzeau Emmanuelle, Glading Jodi, Keane Miriam, Ridge Bronwyn, Zhou Tiger, Burdon Kathryn P, Craig Jamie E

Abstract excerpt

PURPOSE: Predictive genetic testing of relatives of known myocilin (MYOC) gene mutation carriers is an appropriate strategy to identify individuals at risk for glaucoma. It is likely to prevent irreversible blindness in this high-risk group because this treatable condition might otherwise be diagnosed late. The Australian and New Zealand Registry of Advanced Glaucoma has established genetic testing protocols for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytoskeletal Proteins
Share to Eye Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Family

Share to Follow-Up Studies

Share to Glaucoma, Open-Angle

Share to Glycoproteins

Share to New Zealand

Share to Surveys and Questionnaires

Source

Identifiers

PMID: 24406458
DOI: 10.1038/gim.2013.196

Genes

MYOC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive genetic testing experience for myocilin primary open-angle glaucoma using the Australian and New Zealand Registry of Advanced Glaucoma.PMID 24406458Read ↗

Attitudes to predictive DNA testing for myocilin glaucoma: experience with a large Australian family.Semantic proximity Read ↗

Myocilin Predictive Genetic Testing for Primary Open-Angle Glaucoma Leads to Early Identification of At-Risk Individuals.Semantic proximity Read ↗

Attitudes towards glaucoma genetic risk assessment in unaffected individualsSemantic proximity Read ↗

Integrating Genetics in Glaucoma Screening.Semantic proximity Read ↗

Predictive genetic testing in minors for Myocilin juvenile onset open angle glaucoma.Semantic proximity Read ↗

Higher prevalence of myocilin mutations in advanced glaucoma in comparison with less advanced disease in an Australasian disease registry.Semantic proximity Read ↗

Healthcare professionals' knowledge and attitudes towards polygenic risk testing for glaucoma.Semantic proximity Read ↗

The Significance of Screening Family Members in Glaucoma: Opportunities and Challenges.Semantic proximity Read ↗

Glaucoma Pred: Glaucoma prediction based on Myocilin genotype and phenotype information.Semantic proximity Read ↗

Characteristics of p.Gln368Ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank.Semantic proximity Read ↗

The dawn of genetic testing for glaucoma.Semantic proximity Read ↗

Low prevalence of MYOC mutations in UK primary open-angle glaucoma patients limits the utility of genetic testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.